# OnCo record sk-life-science (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sk-life-science/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sk-life-science" ;
  schema:name "SK Life Science"@en ;
  schema:alternateName "SK Life Science, Inc."@en, "SK Life Sciences Inc."@en, "SKLSI"@en ;
  schema:description "SK Life Science is the American arm of the Korean drug maker SK Biopharmaceuticals, best known for epilepsy medicines. It is now developing a radioactive cancer medicine, SKL35501, aimed at tumours that carry the NTSR1 receptor."@en ;
  schema:url <https://onco.cc/companies/sk-life-science/>, <https://www.sklifescienceinc.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sklifescienceinc.com/>, <https://www.sklifescienceinc.com/innovation/>, <https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1146826>, <https://clinicaltrials.gov/study/NCT07812805> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:drugs <https://onco.cc/drugs/skl35501/> .